Amantanium bromide
CAS: 58158-77-3
Ref. 3D-ICA15877
| 1mg | A consultar | ||
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar |
Informação sobre produto
- Amantanium bromide [INN]
- (2-(1-Tricyclo(3.3.1.1(3,7))decylcarbonyloxy)ethyl)decyldimethylammonium bromid
- Amantanil bromidum
- Bromure d'amantanium
- Bromuro de amantanio
- Decyl (2-hydroxyethyl)dimethylammonium bromide 1-adamantanecarboxylate
- Unii-K0435Hzq57
- N,N-dimethyl-N-{2-[(tricyclo[3.3.1.1~3,7~]dec-1-ylcarbonyl)oxy]ethyl}decan-1-aminium bromide
Amantadine is a prodrug that is hydrolyzed in vivo to form the active compound, amantadine triphosphate. It has antiviral activity against influenza virus and other RNA viruses. Amantadine is used to treat influenza A and B infections, as well as symptoms of influenza-like illness. This drug was approved by the FDA in 1967 and has been used as an alternative to neuraminidase inhibitors such as oseltamivir or zanamivir. Amantadine inhibits the release of neurotransmitters from nerve endings and may have some efficacy in treating neurodegenerative diseases such as Parkinson's disease, Huntington's disease, or Alzheimer's disease. Amantadine requires a water vapor to be effective because it is poorly soluble in water.
Propriedades químicas
Consulta técnica sobre: 3D-ICA15877 Amantanium bromide
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
